Starting from 3D volume estimates of serial computerized tomography (CT) scans, Grassberger et al. used mathematical models to estimate the size of resistant and persister populations in EGFR-mutant lung cancer patients during treatment with EGFR inhibitors [128]. Here, EGFR is linked to lung cancer.